HCTZ 12.5 MG losartan potassium 100 MG Oral Tablet

INDICATIONS AND USAGE Hypertension Losartan Potassium and Hydrochlorothiazide Tablets are indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients (see CLINICAL PHARMACOLOGY , Pharmacodynamics and Clinical Effects , and DOSAGE AND ADMINISTRATION ). Hypertensive Patients with Left Ventricular Hypertrophy Losartan Potassium and Hydrochlorothiazide Tablets are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to Black patients. (See PRECAUTIONS , Race , CLINICAL PHARMACOLOGY , Pharmacodynamics and Clinical Effects , Losartan Potassium , Reduction in the Risk of Stroke , Race , and DOSAGE AND ADMINISTRATION ).

Dispensing Solutions, Inc.

FDA Reported Adverse Reactions
[1] diarrhoea    [2] fatigue    [3] drug ineffective    [4] death    [5] nausea    [6] off label use    [7] dyspnoea    [8] pain    [9] vomiting    [10] rash